Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations
Most Popular (6 hours)

SQS India BFSI to hold AGM

- business-standard

Most Popular (24 hours)

Most Popular (a week)

Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations

Angel Broking maintained its BUY rating on Sun Pharmaceutical Industries with a price target of Rs 847, even as the pharma major received 11 observations the US Food and Drug Administration (FDA) for its Dadra unit. The post Angel maintains BUY rating on S

Read on the original site


IDFC s Q4 net profit up 4%

- business-standard

Kokuyo Camlin to hold AGM

- business-standard

Vascon Engineers to hold EGM

- business-standard

EPC Industrie to hold AGM

- business-standard

Eleven tremors jolt Italy

- business-standard
Hashtags:   

Angel

 | 

maintains

 | 

BUY

 | 

rating

 | 

Sun

 | 

Pharma

 | 

despite

 | 

FDA

 | 

observations

 |